Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Psychotrine
Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021
Pentagalloylglucose
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/06/2021
SΔC-Fer
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021
1-((1R)-1-(Hydroxymethyl)-3-(1-naphthyl)propyl)-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
Bisdemethoxycurcumin
Potential treatment - theoretical effect Natural product Antiviral Jan/05/2021
[(3E)-3-[(3,4-Dihydroxyphenyl)methylidene]-2-hydroxycyclohexen-1-yl]-phenylmethanone
Potential treatment - theoretical effect Natural product Antiviral Jan/05/2021
1-(5-Chloro-2-hydroxyphenyl)-3-hydroxy-5-(3,4-dihydroxyphenyl)-2,4-pentadiene-1-one
Potential treatment - theoretical effect Natural product Antiviral Jan/05/2021
Colossolactone G
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Colossolactone E
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Colossolactone VIII
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Velutin
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Heliantriol F
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Ergosterol
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Dihydromyricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Myricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Scutellaria baicalensis extract
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
TMC-310911
Potential treatment - theoretical effect Experimental Antiviral Jan/02/2021
(S)-5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one
Potential treatment - theoretical effect Natural product Antiviral Dec/30/2020
Sulabiroin A
Potential treatment - theoretical effect Natural product Antiviral Dec/30/2020